Biggest winner of the amended Microsoft-OpenAI deal — plus, mixed news for Eli Lilly

the amended microsoft-openai deal lets openai serve products across any cloud provider. amazon ceo andy jassy posted on x that aws will make openai models available on bedrock "in the coming weeks." amazon is up 26% this month. aws hosts a "what's next" event tuesday focused on agentic ai. amazon, microsoft, alphabet, and meta all report earnings wednesday after the bell. eli lilly bought private ajax therapeutics for up to $2.3 billion. ajax's lead drug is an oral type ii jak2 inhibitor in phase 1 for myelofibrosis. separately, leerink cut lilly's price target to $1,058 from $1,296, keeping an outperform rating. the cut reflects a lower multiple — 25x vs 30x on 2027 eps of $42.30 — due to competitive pressure on oral glp-1 foundayo. lilly reports earnings thursday before the open.